Cargando…

Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy

Currently, there is limited data on the immunogenicity and efficacy of human papillomavirus vaccines in Low and Middle income countries (LMIC). The review aims to summarize the current status from published HPV vaccine safety, immunogenicity and efficacy studies in low and middle income countries (L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakalembe, Miriam, Mirembe, Florence M., Banura, Cecily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465311/ https://www.ncbi.nlm.nih.gov/pubmed/26075018 http://dx.doi.org/10.1186/s13027-015-0012-2

Ejemplares similares

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Parents' Knowledge, Risk Perception and Willingness to Allow Young Males to Receive Human Papillomavirus (HPV) Vaccines in Uganda
por: Muhwezi, Wilson Winstons, et al.
Publicado: (2014)

Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10–16 years for an HPV vaccine effectiveness study: a pilot study
por: Nakalembe, Miriam, et al.
Publicado: (2016)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles
por: Banura, Cecily, et al.
Publicado: (2012)

Efficacy and safety of CPAP in low- and middle-income countries
por: Thukral, A, et al.
Publicado: (2016)

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
por: Dorji, Thinley, et al.
Publicado: (2021)

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Screening for Human Papillomavirus in a Low- and Middle-Income Country
por: Atkinson, Aaron E., et al.
Publicado: (2019)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review
por: Banura, Cecily, et al.
Publicado: (2011)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

Food Safety in Low and Middle Income Countries
por: Grace, Delia
Publicado: (2015)

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
por: Garland, S M, et al.
Publicado: (2018)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()
por: Wigle, Jannah, et al.
Publicado: (2013)

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
por: Kabakama, Severin, et al.
Publicado: (2016)

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
por: Howard, N., et al.
Publicado: (2016)

Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis
por: Banura, Cecily, et al.
Publicado: (2013)

Vaccine manufacturing capacity in low- and middle-income countries
por: Khan, Mohammed Imran, et al.
Publicado: (2021)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)

Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials
por: Wilson, Lydia, et al.
Publicado: (2023)

Childhood vaccines and antibiotic use in low- and middle-income countries
por: Lewnard, Joseph A., et al.
Publicado: (2020)

Mapping routine measles vaccination in low- and middle-income countries
Publicado: (2020)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Trends in vaccine investment in middle income countries
por: Onishchenko, K., et al.
Publicado: (2019)

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review
por: Harder, Thomas, et al.
Publicado: (2018)

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries
por: Gohar, Asmaa, et al.
Publicado: (2019)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Publicado: (2021)

COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021)

Perspectives about Food Safety in Diverse Low- and Middle-income Countries
por: Isanovic, Sejla, et al.
Publicado: (2022)

Addressing quality and safety in anatomic pathology in low- and middle-income countries
por: Smith, Stephen M., et al.
Publicado: (2022)

Road safety in low- and middle-income countries: Role of police strike
por: Ogunyemi, Kehinde O, et al.
Publicado: (2022)

Role and utility of COVID-19 laboratory testing in low-income and middle-income countries: protocol for rapid evidence synthesis
por: Ouma, Ojiambo Kevin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eh56415bheisluiqotgklbst8c